Has Sudhir Kadian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,843 in general payments to Sudhir Kadian, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sudhir Kadian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sudhir Kadian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sudhir Kadian, MD

Anesthesiology · New London, CTNPI 1366497182

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.2% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,843in general payments, 2019–2025

Across 66 payments — averaging $43.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$669
SPR Therapeutics, Inc$507
Boston Scientific$292
MML US, Inc.$218
Abbott$199
Saluda Medical Americas, Inc.$175
plus $783 from 14 others

What the payments were for

Travel & lodging$1947%
Food & beverage$2,64993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	16	$669
SPR Therapeutics, Inc	11	$507
Boston Scientific	5	$292
MML US, Inc.	3	$218
Abbott	7	$199
Saluda Medical Americas, Inc.	1	$175
Curonix LLC	1	$137
Si-bone, Inc.	3	$134
Vertos Medical, Inc.	1	$128
Tersera Therapeutics LLC	4	$74
Scilex Pharmaceuticals Inc.	2	$46
Johnson & Johnson(2 entities)	2	$44
Medtronic	2	$41
Pacira Pharmaceuticals Incorporated	1	$37
AbbVie	2	$33
Pfizer	1	$27
Orthofix Medical, Inc.	1	$26
Pacira Therapeutics, Inc.	1	$24
Stryker	1	$19
Acelrx Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRINT PNS System$319
Evoke$175
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$137
Senza$135
mild Device Kit$128
Omnia$122
ReActiv8$109

How this compares

$2,843 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.

See all anesthesiology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$68,457

Medicare patients

251

Services billed

573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Baclofen	60	$851
Gabapentin	84	$771
Fentanyl	11	$641
Cyclobenzaprine Hcl	58	$627
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	26	$467
Oxycodone Hcl	21	$303
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	15	$206
Tizanidine Hcl	16	$192
Meloxicam	23	$44
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen	11	$42

Paid to pharmacies, not to this prescriber.

Other anesthesiology in New London

Glenn BradyNew London$2K
Zeev KainNew Haven$273K
Alison ConsidineNew Haven$82K
Sanjay SinhaHartford$42K
William RosenblattNew Haven$40K
Paul HeerdtNew Haven$36K
Antonio PazBrookfield$27K
Honghui FengOld Saybrook$20K
Prakash PatelNew Haven$20K
Aymen AlianNew Haven$17K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →